HK1076054A1 - Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease - Google Patents

Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease

Info

Publication number
HK1076054A1
HK1076054A1 HK05110538.3A HK05110538A HK1076054A1 HK 1076054 A1 HK1076054 A1 HK 1076054A1 HK 05110538 A HK05110538 A HK 05110538A HK 1076054 A1 HK1076054 A1 HK 1076054A1
Authority
HK
Hong Kong
Prior art keywords
allergic
disease
prevention
extract
treatment
Prior art date
Application number
HK05110538.3A
Other languages
English (en)
Inventor
Bongcheol Kim
Mirim Jin
Eun-Jin Park
Hyung-Jin Jung
Sung-Seup Shin
Jin-Hwan Oh
Hwa Jun Lee
Sunyoung Kim
Hyang Jeon
Original Assignee
Helixir Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helixir Co Ltd filed Critical Helixir Co Ltd
Publication of HK1076054A1 publication Critical patent/HK1076054A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/304—Foods, ingredients or supplements having a functional effect on health having a modulation effect on allergy and risk of allergy
HK05110538.3A 2002-08-23 2005-11-22 Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease HK1076054A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40529502P 2002-08-23 2002-08-23
PCT/KR2003/001621 WO2004017982A1 (en) 2002-08-23 2003-08-12 Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease

Publications (1)

Publication Number Publication Date
HK1076054A1 true HK1076054A1 (en) 2006-01-06

Family

ID=31946849

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05110538.3A HK1076054A1 (en) 2002-08-23 2005-11-22 Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease

Country Status (17)

Country Link
US (2) US9131722B2 (xx)
EP (2) EP2329835B8 (xx)
JP (3) JP4620461B2 (xx)
KR (2) KR100615389B1 (xx)
CN (1) CN1678333B (xx)
AU (1) AU2003251197B2 (xx)
BR (1) BR0313983A (xx)
CA (1) CA2495542C (xx)
CL (1) CL2004002241A1 (xx)
ES (1) ES2428079T3 (xx)
HK (1) HK1076054A1 (xx)
IL (1) IL167036A (xx)
MX (1) MXPA05002087A (xx)
NZ (2) NZ538971A (xx)
RU (1) RU2317821C2 (xx)
WO (1) WO2004017982A1 (xx)
ZA (1) ZA200501666B (xx)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100111927A1 (en) * 2002-08-23 2010-05-06 Sunyoung Kim Compositions Comprising Actinidia and Methods of Use Thereof
KR100615389B1 (ko) * 2002-08-23 2006-08-25 (주)헬릭서 다래 추출물을 함유하는 알러지성 질환 및 비알러지성염증 질환의 예방 및 개선용 건강 기능 식품
EP1660531A2 (en) 2003-08-05 2006-05-31 Novo Nordisk A/S Novel insulin derivatives
NZ532254A (en) * 2004-04-08 2006-03-31 Dragon Pacific Ltd Kiwifruit extract and a method for producing powdered kiwifruit extract
ATE547112T1 (de) * 2004-08-10 2012-03-15 Helixir Co Ltd Zusammensetzung aus dem extrakt von actinidia arguta zur prävention und behandlung von alopezie und seborrhöischen hauterkrankungen
JP4717413B2 (ja) * 2004-10-22 2011-07-06 森永乳業株式会社 脂質代謝改善用組成物
TWI385007B (zh) * 2005-02-25 2013-02-11 Efficas Inc 包含獼猴桃（Ａｃｔｉｎｉｄｉａ）之組成物及其使用方法
US20080175888A1 (en) * 2005-02-25 2008-07-24 Julie Lindemann Combination Therapy Comprising Actinidia and Steroids and Uses Thereof
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
EP1969004B1 (en) 2005-12-28 2011-08-10 Novo Nordisk A/S Compositions comprising an acylated insulin and zinc and method of making the said compositions
JP5462430B2 (ja) * 2006-01-19 2014-04-02 オリザ油化株式会社 抗炎症剤及び鎮痛剤
AT503521A1 (de) * 2006-05-05 2007-11-15 Omnica Gmbh Verwendung eines extraktes von kiwi-frucht
KR101310981B1 (ko) * 2006-06-05 2013-09-25 충북대학교 산학협력단 괴각 추출물을 유효성분으로 함유하는 알레르기 질환의예방 및 개선용 조성물
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
JP5306605B2 (ja) * 2007-03-12 2013-10-02 株式会社ノエビア 皮膚外用剤
US20100143319A1 (en) * 2007-05-03 2010-06-10 Vital Food Processors Limited Kiwifruit compositions
KR100880712B1 (ko) * 2007-05-17 2009-02-02 건국대학교 산학협력단 탄닌 함유 목천료자 추출물을 유효성분으로 하는 소염 진통제 조성물
WO2008152106A1 (en) 2007-06-13 2008-12-18 Novo Nordisk A/S Pharmaceutical formulation comprising an insulin derivative
JP5710091B2 (ja) * 2007-08-20 2015-04-30 丸善製薬株式会社 Ｎｏ産生促進剤
WO2009114828A1 (en) * 2008-03-13 2009-09-17 Childrens Hospital Medical Center Compositions and methods relating to gastrointestinal allergic conditions
WO2010049488A1 (en) 2008-10-30 2010-05-06 Novo Nordisk A/S Treating diabetes melitus using insulin injections with less than daily injection frequency
BRPI0923551A2 (pt) * 2008-12-24 2016-01-26 Ecobiotics Ltd extratos de planta da espécie acronichia e seus usos
KR101144117B1 (ko) * 2009-09-01 2012-05-24 계명대학교 산학협력단 개다래 박 추출물의 제조방법 및 이를 함유하는 염증 또는 알러지 예방 및 치료용 조성물
KR101326158B1 (ko) * 2009-12-15 2013-11-06 재단법인 제주테크노파크 항히스타민제 조성물
US20110206798A1 (en) * 2010-02-24 2011-08-25 Matatabby, Inc. Feline stimulant and method of manufacture
RU2013123515A (ru) 2010-10-27 2014-12-10 Ново Нордиск А/С Лечение сахарного диабета с помощью инъекций инсулина, вводимых с различными интервалами
EP2648741B1 (en) * 2010-12-07 2015-12-02 University Of Oslo Cardio-protective agents from kiwifruits
CN102057938B (zh) * 2010-12-23 2013-11-20 西北大学 猕猴桃树溃疡病防治剂及其使用方法
US9962361B2 (en) 2011-01-03 2018-05-08 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US10647668B2 (en) 2011-01-03 2020-05-12 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US10640464B2 (en) 2011-01-03 2020-05-05 The William M. Yarbrough Foundation Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
US8933119B2 (en) 2011-01-03 2015-01-13 The William M. Yarbrough Foundation Method for treating phytophotodermatitis
US10273205B2 (en) 2011-01-03 2019-04-30 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
US10308599B2 (en) 2011-01-03 2019-06-04 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US11279674B2 (en) 2011-01-03 2022-03-22 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US11407713B2 (en) 2011-01-03 2022-08-09 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US8865765B2 (en) 2011-01-12 2014-10-21 The William M. Yarbrough Foundation Method for treating eczema
US9532969B2 (en) 2011-02-08 2017-01-03 The William M. Yarbrough Foundation Method for treating psoriasis
US8865772B2 (en) 2012-07-26 2014-10-21 The William M. Yarbrough Foundation Method for treating skin cancer
US10080734B2 (en) 2012-07-26 2018-09-25 The William M. Yarbrough Foundation Method for treating autism and other neurodevelopmental disorders
US9949943B2 (en) 2012-07-26 2018-04-24 The William M. Yarbrough Foundation Method for treating neurodegenerative diseases
US10434081B2 (en) 2012-07-26 2019-10-08 The William M. Yarbrough Foundation Inhibitors of macrophage migration inhibitory factor
US10441561B2 (en) 2012-07-26 2019-10-15 The William M. Yanbrough Foundation Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
US10335387B2 (en) 2012-07-26 2019-07-02 The William M. Yarbrough Foundation Method for treating infectious diseases with isothiocyanate functional compounds
US9839621B2 (en) 2012-07-26 2017-12-12 The William M. Yarbrough Foundation Method for treating bladder cancer
US10434082B2 (en) 2012-07-26 2019-10-08 The William M. Yarbrough Foundation Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms
JP2016519127A (ja) 2013-04-30 2016-06-30 ノヴォ ノルディスク アー／エス 新規投与レジメン
KR101662887B1 (ko) * 2014-07-10 2016-10-05 인제대학교 산학협력단 다래순 추출물을 유효성분으로 포함하는 비알콜성 지방간의 예방 또는 치료용 조성물
KR101698163B1 (ko) * 2014-12-19 2017-01-19 동아에스티 주식회사 복령피 추출물을 함유하는 퇴행성 신경질환의 예방, 개선 또는 치료용 조성물
CN104906156B (zh) * 2015-06-09 2018-10-26 吉林大学珠海学院 猕猴桃提取物在制备提高记忆力药物中的医用用途
WO2019103497A1 (ko) * 2017-11-23 2019-05-31 주식회사 바이로메드 천연추출물을 포함하는 소양증의 예방 또는 치료용 조성물
KR101963628B1 (ko) * 2017-12-20 2019-03-29 안동대학교 산학협력단 초고압 균질화 공정을 통해 얻은 미후등 추출물을 유효성분으로 함유하는 항염증용 조성물
KR20190080013A (ko) 2017-12-28 2019-07-08 (주)흥아 바이어스 타이어
CN108309883A (zh) * 2018-04-09 2018-07-24 安徽科技学院 一种禹州漏芦抗菌保健沐浴露及其制备方法
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
CN109793680B (zh) * 2018-12-25 2022-04-19 深圳市唯可依日用品有限公司 一种护肤复合水果植物抗敏提取液及其制备方法和应用
US20220193163A1 (en) * 2019-04-24 2022-06-23 G&P Bioscience Co., Ltd. Composition comprising actinidia polygama extract for alleviating skin damage or moisturizing skin
KR102177835B1 (ko) 2019-05-08 2020-11-11 (주)다래월드 물 없이 씻는 바디워시 조성물 및 그 제조방법
JP7301347B2 (ja) * 2019-05-22 2023-07-03 株式会社ブルーム・クラシック サーチュイン１活性化剤及びサーチュイン１活性化用皮膚化粧料
KR102248170B1 (ko) * 2019-10-30 2021-05-07 이스트힐(주) 참다래 줄기 추출물을 유효성분으로 함유하는 피부 재생 또는 상처 치유용 조성물
CN113264633B (zh) * 2021-04-20 2023-04-28 广西壮族自治区环境保护科学研究院 一种黑臭河道生态修复方法
KR102515520B1 (ko) * 2022-09-16 2023-03-29 (주)영월드씨케이씨 지역 특산물을 이용한 기능성 초콜릿 제조방법
KR102515523B1 (ko) * 2022-09-16 2023-03-29 (주)영월드씨케이씨 생리증후군 개선용 초콜릿 제조방법

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3808312A (en) 1971-07-14 1974-04-30 Robins Co Inc A H Long lasting euphoriant resin for cats
US4444780A (en) 1982-08-30 1984-04-24 Ortho Pharmaceutical Corporation Method for treating atopic dermatitis
JPS61140510A (ja) * 1984-12-13 1986-06-27 Junichi Udagawa キウイ液の製造方法
JPS62146581A (ja) * 1985-12-20 1987-06-30 Ichimaru Fuarukosu Kk キウイ果実水溶性抽出物及びそれを含有する化粧料又は浴用料
JPH02202808A (ja) 1989-01-31 1990-08-10 Ichimaru Pharcos Co Ltd キウイ果実エキス溶液又はその濃縮エキス
DK0384798T3 (da) 1989-02-06 1993-12-06 Soma Genichiro Limulustest-positivt planteglycolipid samt fremgangsmåde til stimulering af et dyrs immunsystem
JPH0319666A (ja) * 1989-06-14 1991-01-28 Akira Shirota 食品添加物
US5177060A (en) * 1990-01-09 1993-01-05 Regents Of The University Of California Anti-inflammatory peptides and treatment to inhibit vascular leakage in injured tissues
NZ235972A (en) * 1990-11-06 1995-04-27 Amaranathan Balasingham Fruit product by soft pulping after skin removal
KR920011752A (ko) 1990-12-27 1992-07-24 한태희 레이져 빔 프린터의 절전제어 시스템
KR940001893A (ko) 1992-07-02 1994-02-16 강삼식 인동(Lonicera japonica)으로부터 얻는 바이후라보노이드(biflavonoid)의 항염증, 항알러지 및 항류마티스 작용제
NZ243986A (en) * 1992-08-17 1997-07-27 Nekta International Ltd Substi Dairy substitute whose viscosity increases under shear force, made by filtering and deodourising kiwifruit pulp
GB9301629D0 (en) 1993-01-27 1993-03-17 Scotia Holdings Plc Formulations containing unsaturated fatty acids
JP3415198B2 (ja) * 1993-06-30 2003-06-09 三省製薬株式会社 皮膚外用剤
CN1107308A (zh) * 1994-02-25 1995-08-30 中国癌症研究基金会 猕猴桃天然营养口服液
JPH07313071A (ja) * 1994-05-27 1995-12-05 Sansho Kk 餌 料
NL9401190A (nl) 1994-07-20 1996-03-01 Applied Power Inc Hydraulische schakeling.
JP3749743B2 (ja) * 1995-07-11 2006-03-01 株式会社ロッテ 喉炎症起因菌に対する抗菌活性及び溶血毒に対する阻害活性剤並びにそれを含有する口腔用組成物及び飲食品
PT843557E (pt) * 1995-07-21 2003-03-31 Applied Research Systems Metodos para detectar indentificar isolar e etiquetar e abordar selectivamente linfocitos th1 por intermedio da proteina lag-3
RU2112524C1 (ru) 1995-11-16 1998-06-10 Борис Моисеевич Кершенгольц Композиция ингредиентов для лекарственного средства
JPH10194979A (ja) 1997-01-07 1998-07-28 Teika Corp イムノグロブリンｅ抗体産生抑制剤
DE19758090B4 (de) * 1997-12-18 2008-10-16 Maria Endres Zusammensetzung und deren Verwendung in Kosmetik und Medizin
ZA99499B (en) * 1998-01-23 1999-07-22 Nat Jewish Medical Res Ct Method for treating inflammatory diseases using heat shock proteins.
US6369091B1 (en) 1998-05-22 2002-04-09 Avanir Pharmaceuticals Benzimidazole analogs as down-regulators of IgE
CA2298349C (en) * 1999-02-16 2008-11-18 Sunstar Inc. Antiallergic composition and antipruritic composition
JP4194196B2 (ja) * 1999-02-22 2008-12-10 花王株式会社 浴用剤組成物
US6630163B1 (en) * 1999-04-22 2003-10-07 Howard Murad Method of treating dermatological disorders with fruit extracts
KR100344147B1 (ko) * 1999-08-17 2002-07-22 박용서 다래수액을 주재로 한 건강음료 및 그 제조방법
AU2000227285A1 (en) * 2000-01-14 2001-07-24 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Methods of regulating il-12 production by administering ccr5 agonists and antagonists
JP3851750B2 (ja) * 2000-01-27 2006-11-29 株式会社コーセー 皮膚外用剤
JP2001220344A (ja) * 2000-02-09 2001-08-14 Ichimaru Pharcos Co Ltd 植物水蒸気蒸留水含有化粧料組成物
WO2001070259A1 (en) 2000-03-21 2001-09-27 Bruce William Donaldson Improvements in and relating to digestive/laxative compositions
KR20010096881A (ko) * 2000-04-15 2001-11-08 김영호 액티니디아 아르쿠타로부터 분리한 항종양성 추출물 및엽록소 유도체
EP1293131A4 (en) 2000-06-21 2005-10-19 Kao Corp THERAPEUTIC AGENTS FOR THE THROAT
US6991812B2 (en) 2000-09-05 2006-01-31 Kao Corporation Agent for preventing, improving or treating hypertension
JP2002145754A (ja) * 2000-11-07 2002-05-22 Personal Cosmedic Kk 皮膚化粧料
US20040175439A1 (en) 2001-03-02 2004-09-09 Benoit Cyr Plant extracts and compositions comprising extracellular protease inhibitors
JP3983003B2 (ja) * 2001-03-15 2007-09-26 株式会社ファンケル グルタチオン増強用組成物
JP2003061615A (ja) * 2001-08-27 2003-03-04 Niigata Prefecture テロメラーゼ阻害剤及び食品組成物
JP2003171294A (ja) 2001-12-04 2003-06-17 Nof Corp 血栓抑制剤および組成物
US20030131370A1 (en) 2001-12-14 2003-07-10 Pfizer Inc. Disruption of the glutathione S-transferase-Omega-1 gene
WO2003103415A1 (en) 2002-06-07 2003-12-18 Ann De Wees Allen Novel sweetener compositions and methods of use
KR100615389B1 (ko) * 2002-08-23 2006-08-25 (주)헬릭서 다래 추출물을 함유하는 알러지성 질환 및 비알러지성염증 질환의 예방 및 개선용 건강 기능 식품
US20100111927A1 (en) 2002-08-23 2010-05-06 Sunyoung Kim Compositions Comprising Actinidia and Methods of Use Thereof
KR20070007837A (ko) 2004-03-23 2007-01-16 라이프라인 뉴트러세티컬스 코포레이션 포유류에서 염증과 산화적 스트레스 완화를 위한 조성물 및방법

Also Published As

Publication number Publication date
CN1678333B (zh) 2010-04-28
RU2005105774A (ru) 2005-10-27
AU2003251197A1 (en) 2004-03-11
ES2428079T3 (es) 2013-11-06
MXPA05002087A (es) 2005-06-06
RU2317821C2 (ru) 2008-02-27
US20070122508A1 (en) 2007-05-31
JP2006504676A (ja) 2006-02-09
KR20040018117A (ko) 2004-03-02
KR100511550B1 (ko) 2005-08-31
AU2003251197B2 (en) 2007-08-16
BR0313983A (pt) 2005-07-19
EP1551433A1 (en) 2005-07-13
US20040037909A1 (en) 2004-02-26
NZ574363A (en) 2010-01-29
EP1551433B1 (en) 2012-10-17
JP2013056931A (ja) 2013-03-28
EP2329835A1 (en) 2011-06-08
KR100615389B1 (ko) 2006-08-25
JP5204805B2 (ja) 2013-06-05
EP2329835B8 (en) 2013-09-11
CL2004002241A1 (es) 2008-05-23
CN1678333A (zh) 2005-10-05
CA2495542A1 (en) 2004-03-04
CA2495542C (en) 2012-05-01
JP4620461B2 (ja) 2011-01-26
US9131722B2 (en) 2015-09-15
NZ538971A (en) 2009-03-31
AU2003251197B9 (en) 2004-03-11
IL167036A (en) 2010-04-15
ZA200501666B (en) 2005-11-30
EP2329835B1 (en) 2013-07-31
EP1551433A4 (en) 2009-07-01
JP2010213717A (ja) 2010-09-30
WO2004017982A1 (en) 2004-03-04
KR20040018118A (ko) 2004-03-02

Similar Documents

Publication Publication Date Title
HK1076054A1 (en) Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease
IL257622B (en) Methods and preparations for the treatment of persistent infections
EP1711197A4 (en) METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASES OR DISORDERS
EP1628530A4 (en) METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF SEPSIA
IL180752A0 (en) Compositions and methods of using angiopoietin-like 4 protein
EP1575480A4 (en) COMPOSITIONS AND METHODS FOR TREATING DISEASES RELATED TO THE IMMUNE SYSTEM
EP1578367A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE DISEASES
EP1572116A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE DISEASES
EP1576137A4 (en) COMPOSITIONS AND METHODS FOR TREATING DISEASES RELATED TO THE IMMUNE SYSTEM
AU2003231866A8 (en) Herbs and herbal combinations useful for the treatment of microbial infections
IL174627A0 (en) Compositions and methods for treatment of burns
ZA200705297B (en) Methods and compositions for treating amyloid related diseases
EP1680145A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROLOGICAL DISEASES
AU2003249645A8 (en) Methods for the identification of ikkalpha function and other genes useful for treatment of inflammatory diseases
EP1512415A4 (en) LURE COMPOSITION FOR TREATING AND PREVENTING INFLAMMATORY DISEASES
EP1722771A4 (en) COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING AN INFLAMMATORY REACTION
PL371281A1 (en) Methods and compositions for the treatment of eye diseases
NO20054346D0 (no) Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander
WO2004091436A3 (en) Methods and compositions for treating ocular disease
IL155174A0 (en) Methods and compositions for the treatment of inflammatory diseases
EP1682171A4 (en) COMPOSITIONS AND METHODS OF TREATING NEUROLOGICAL ILLNESSES
AU2002309180A1 (en) Composition and kit for the treatment of inflammatory bowel diseases
WO2005044244A3 (de) Verwendung von mrp4-inhibitoren zur behandlung und/oder prophylaxe kardiovaskulärer erkrankungen
EP1781318A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF POLYKYSTIC DISEASES
HK1101674A1 (en) Composition for the prevention and treatment of allergic inflammatory disease

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20230811